Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas

Kun Huei Yeh, Ann Lii Cheng, I. H Jen Su, Ming-Tseh Lin, Hwei Fang Tien, Ming Chin Shen, Chiu Hwa Wang, Yao Chang Chen

Research output: Contribution to journalArticle

Abstract

Adult lymphoblastic lymphoma (LBL) can be of T-cell or B-cell lineage. However, the clinical significance of immunophenotypes is largely unknown. We conducted a retrospective study to compare T-cell LBL with its B-cell counterpart. Between 1983 and 1995, 50 adult patients were diagnosed as LBL at National Taiwan University Hospital. Twenty-seven patients (T-LBL:20 and B-LBL:7) had adequate clinical information and formed the basis of final analysis. Pertinent characteristics, including sex, age, and lymphoma stages of these two groups of patients were identical. Detailed clinical features were compared. Systemic involvements of lymphoma were similar except that T-cell LBL had significantly more mediastinal involvement (T:B = 70%:14.3%, p = 0.011). CNS involvement was high in both groups (T:B = 50%:28.6%, p = NS). B-cell LBL had a better overall survival than T-cell LBL, although the survival benefit became less significant after 30 months. The median survival of T- and B-cell LBL was 8 and 31 months, respectively. Both groups taken together, patients who had received prophylactic cranial irradiation had a better overall survival (p <0.01). We suggest that: a) B-cell LBL has a relatively favorable prognosis than T-cell LBL, at least in the initial 2 to 3 years; b) except for mediastinal involvement, the clinical presentation of T- and B-cell LBL appears to be similar; c) treatment policy, such as the need of prophylactic cranial irradiation, of these two groups may also be similar.

Original languageEnglish (US)
Pages (from-to)2269-2272
Number of pages4
JournalAnticancer Research
Volume17
Issue number3 C
StatePublished - 1997
Externally publishedYes

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
T-Cell Lymphoma
B-Cell Lymphoma
Cranial Irradiation
Survival
Lymphoma
B-Lymphocytes
Cell Lineage
Taiwan
Sex Characteristics
Retrospective Studies
T-Lymphocytes

Keywords

  • Adult
  • B-cell
  • Lymphoblastic lymphoma
  • T-cell

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yeh, K. H., Cheng, A. L., Su, I. H. J., Lin, M-T., Tien, H. F., Shen, M. C., ... Chen, Y. C. (1997). Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas. Anticancer Research, 17(3 C), 2269-2272.

Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas. / Yeh, Kun Huei; Cheng, Ann Lii; Su, I. H Jen; Lin, Ming-Tseh; Tien, Hwei Fang; Shen, Ming Chin; Wang, Chiu Hwa; Chen, Yao Chang.

In: Anticancer Research, Vol. 17, No. 3 C, 1997, p. 2269-2272.

Research output: Contribution to journalArticle

Yeh, KH, Cheng, AL, Su, IHJ, Lin, M-T, Tien, HF, Shen, MC, Wang, CH & Chen, YC 1997, 'Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas', Anticancer Research, vol. 17, no. 3 C, pp. 2269-2272.
Yeh KH, Cheng AL, Su IHJ, Lin M-T, Tien HF, Shen MC et al. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas. Anticancer Research. 1997;17(3 C):2269-2272.
Yeh, Kun Huei ; Cheng, Ann Lii ; Su, I. H Jen ; Lin, Ming-Tseh ; Tien, Hwei Fang ; Shen, Ming Chin ; Wang, Chiu Hwa ; Chen, Yao Chang. / Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas. In: Anticancer Research. 1997 ; Vol. 17, No. 3 C. pp. 2269-2272.
@article{af4431cc54564d95b6383f498a0ae936,
title = "Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas",
abstract = "Adult lymphoblastic lymphoma (LBL) can be of T-cell or B-cell lineage. However, the clinical significance of immunophenotypes is largely unknown. We conducted a retrospective study to compare T-cell LBL with its B-cell counterpart. Between 1983 and 1995, 50 adult patients were diagnosed as LBL at National Taiwan University Hospital. Twenty-seven patients (T-LBL:20 and B-LBL:7) had adequate clinical information and formed the basis of final analysis. Pertinent characteristics, including sex, age, and lymphoma stages of these two groups of patients were identical. Detailed clinical features were compared. Systemic involvements of lymphoma were similar except that T-cell LBL had significantly more mediastinal involvement (T:B = 70{\%}:14.3{\%}, p = 0.011). CNS involvement was high in both groups (T:B = 50{\%}:28.6{\%}, p = NS). B-cell LBL had a better overall survival than T-cell LBL, although the survival benefit became less significant after 30 months. The median survival of T- and B-cell LBL was 8 and 31 months, respectively. Both groups taken together, patients who had received prophylactic cranial irradiation had a better overall survival (p <0.01). We suggest that: a) B-cell LBL has a relatively favorable prognosis than T-cell LBL, at least in the initial 2 to 3 years; b) except for mediastinal involvement, the clinical presentation of T- and B-cell LBL appears to be similar; c) treatment policy, such as the need of prophylactic cranial irradiation, of these two groups may also be similar.",
keywords = "Adult, B-cell, Lymphoblastic lymphoma, T-cell",
author = "Yeh, {Kun Huei} and Cheng, {Ann Lii} and Su, {I. H Jen} and Ming-Tseh Lin and Tien, {Hwei Fang} and Shen, {Ming Chin} and Wang, {Chiu Hwa} and Chen, {Yao Chang}",
year = "1997",
language = "English (US)",
volume = "17",
pages = "2269--2272",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 C",

}

TY - JOUR

T1 - Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas

AU - Yeh, Kun Huei

AU - Cheng, Ann Lii

AU - Su, I. H Jen

AU - Lin, Ming-Tseh

AU - Tien, Hwei Fang

AU - Shen, Ming Chin

AU - Wang, Chiu Hwa

AU - Chen, Yao Chang

PY - 1997

Y1 - 1997

N2 - Adult lymphoblastic lymphoma (LBL) can be of T-cell or B-cell lineage. However, the clinical significance of immunophenotypes is largely unknown. We conducted a retrospective study to compare T-cell LBL with its B-cell counterpart. Between 1983 and 1995, 50 adult patients were diagnosed as LBL at National Taiwan University Hospital. Twenty-seven patients (T-LBL:20 and B-LBL:7) had adequate clinical information and formed the basis of final analysis. Pertinent characteristics, including sex, age, and lymphoma stages of these two groups of patients were identical. Detailed clinical features were compared. Systemic involvements of lymphoma were similar except that T-cell LBL had significantly more mediastinal involvement (T:B = 70%:14.3%, p = 0.011). CNS involvement was high in both groups (T:B = 50%:28.6%, p = NS). B-cell LBL had a better overall survival than T-cell LBL, although the survival benefit became less significant after 30 months. The median survival of T- and B-cell LBL was 8 and 31 months, respectively. Both groups taken together, patients who had received prophylactic cranial irradiation had a better overall survival (p <0.01). We suggest that: a) B-cell LBL has a relatively favorable prognosis than T-cell LBL, at least in the initial 2 to 3 years; b) except for mediastinal involvement, the clinical presentation of T- and B-cell LBL appears to be similar; c) treatment policy, such as the need of prophylactic cranial irradiation, of these two groups may also be similar.

AB - Adult lymphoblastic lymphoma (LBL) can be of T-cell or B-cell lineage. However, the clinical significance of immunophenotypes is largely unknown. We conducted a retrospective study to compare T-cell LBL with its B-cell counterpart. Between 1983 and 1995, 50 adult patients were diagnosed as LBL at National Taiwan University Hospital. Twenty-seven patients (T-LBL:20 and B-LBL:7) had adequate clinical information and formed the basis of final analysis. Pertinent characteristics, including sex, age, and lymphoma stages of these two groups of patients were identical. Detailed clinical features were compared. Systemic involvements of lymphoma were similar except that T-cell LBL had significantly more mediastinal involvement (T:B = 70%:14.3%, p = 0.011). CNS involvement was high in both groups (T:B = 50%:28.6%, p = NS). B-cell LBL had a better overall survival than T-cell LBL, although the survival benefit became less significant after 30 months. The median survival of T- and B-cell LBL was 8 and 31 months, respectively. Both groups taken together, patients who had received prophylactic cranial irradiation had a better overall survival (p <0.01). We suggest that: a) B-cell LBL has a relatively favorable prognosis than T-cell LBL, at least in the initial 2 to 3 years; b) except for mediastinal involvement, the clinical presentation of T- and B-cell LBL appears to be similar; c) treatment policy, such as the need of prophylactic cranial irradiation, of these two groups may also be similar.

KW - Adult

KW - B-cell

KW - Lymphoblastic lymphoma

KW - T-cell

UR - http://www.scopus.com/inward/record.url?scp=0030838696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030838696&partnerID=8YFLogxK

M3 - Article

C2 - 9216700

AN - SCOPUS:0030838696

VL - 17

SP - 2269

EP - 2272

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 C

ER -